3DPrint.com October 31, 2023
Vanesa Listek

Imagine a world where we can mimic the way cancer grows and evolves in the human body without actually relying on human trials. Building on this vision, scientists from CTIBiotech in France and Bulgaria’s Medical University of Plovdiv, with the help of biotech firm Transgene, have taken a monumental step towards that reality.

This groundbreaking research, titled World’s First Long-Term Colorectal Cancer Model by 3D Bioprinting as a Mechanism for Screening Oncolytic Viruses, was published in a special issue of the medical journal Cancers MDPI on Recent Advances in Basic and Clinical Colorectal Cancer Research.

Understanding the challenge

Colorectal cancer, or colon cancer, is a primary global health concern. Every year, over 1.8 million people are diagnosed with this deadly...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: 3D Printing, Biotechnology, Pharma / Biotech, Technology
STAT+: NVIDIA’s Kimberly Powell touts progress on AI in drug discovery
Big pharma ignores low-cost migraine solution
Sanders: Weight loss drug could bankrupt healthcare system
J&J Joins Chase for Hot Immunology Target With $850M Proteologix Acquisition
Going beyond A, B & O: Thermo Fisher unveils DNA test for the rarest blood types

Share This Article